Mesothelioma - 56 Studies Found
| Recruiting |
: Vinorelbine in Mesothelioma : Mesothelioma : 2014-05-09 :
|
| Completed |
: Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma : Mesothelioma : 2006-02-22 :
|
| Completed |
: Do Your Genes Put You at a Higher Risk of Developing Mesothelioma : Mesothelioma : 2012-04-23 |
| Terminated |
: An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma : Mesothelioma : 2008-01-09 :
|
| Recruiting |
: Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma : Mesothelioma : 2013-09-21 |
| Recruiting |
: A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma : Pleural Mesothelioma : 2016-02-29 :
|
| Active, not recruiting |
: Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients : Mesothelioma : 2016-03-09 :
|
| Completed |
: Dendritic Cell-based Immunotherapy in Mesothelioma : Malignant Pleural Mesothelioma : 2006-01-20 : Biological: tumor lysate-loaded autologous dendritic cells 50x10e6 cells per vaccination, 3 times, 2 wee |
| Recruiting |
: PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma : Mesothelioma : 2012-05-21 : Radiation: Prophylactic Irradiation of Tracts (PIT) 21 Gy in 3 fractions |
| Completed |
: Serum Biomarkers in Diagnosis of Mesothelioma : Mesothelioma : 2014-01-06 : Biological: Mesothelin, hyaluronan, osteopontin, syndecan-1 We compere the serum levels of the tumor mar |